MoFo News Item

MoFo Advises Marrone Bio Innovations on Merger with Bioceres Crop Solutions

17 Mar 2022

Morrison & Foerster advised Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“MBI”) in connection with its agreement to combine with Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres”) in an all-stock transaction. The transaction is expected to close in the third quarter of 2022.

MBI is a growth-oriented agricultural company leading the movement to environmentally sustainable farming practices through the discovery, development, and sale of innovative biological products for crop production, crop health, and crop nutrition. The transaction will combine MBI’s leadership in the development of crop protection and plant health solutions with Bioceres’ expertise in bionutrition and seed care products, creating a global leader in the development and commercialization of sustainable agricultural solutions.

The MoFo team advising MBI was led by San Francisco corporate partners Alfredo Silva and Michael O’Bryan and New York partner Joe Sulzbach.



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.